A clinical trial involving desmopressin was posted on August 20, 2026. The study, titled "Bedtime Device Restriction and Desmopressin in PMNE," is registered under identifier NCT07776977. Its current status is listed as not yet recruiting, and no phase is specified for this trial. The registration indicates the study will examine desmopressin in combination with bedtime device restriction in the context of PMNE. No enrollment activity has begun as of the listed date. Since the trial has not yet started recruiting, no participant outcomes, safety findings, or efficacy data are available at this time. Further details, including eligibility criteria and timeline, are expected to be updated on the official registry page as the study progresses toward recruitment. Interested parties can track updates directly through the clinical trial registration. This update reflects only the administrative status of the trial as registered and does not represent any results or interim findings. For general background on desmopressin, readers can consult the compound overview for additional context.
Trial Update: Desmopressin Studied With Bedtime Device Restriction in PMNE
See the full desmopressin overview
Source: https://clinicaltrials.gov/study/NCT07776977